Klaricid IV 500 mg is indicated in adults and children 12 years and older. Klaricid IV 500 mg is indicated whenever parenteral therapy is required for treatment of infections caused by susceptible organisms in the following conditions; - Lower respiratory tract infections for example, acute and chronic bronchitis, and pneumonia (see section 4.4 and 5.1 regarding Sensitivity Testing). - Upper respiratory tract infections for example, sinusitis and pharyngitis. - Skin and soft tissue infections (e.g. folliculitis, cellulitis, erysipelas) (see section 4.4 and 5.1 regarding Sensitivity Testing). Consideration should be given to official guidance on the appropriate use of antibacterial agents.